{
    "nctId": "NCT04996836",
    "briefTitle": "Breast Cancer, Omics, and Precision Medicine",
    "officialTitle": "Evaluating the Predictive and Prognostic Power of the Early Breast canceR gEnetic and Epigenetic Abnormalities Through Liquid biopSy and neTwOrk MEdicine Algorithm: the BR(E)2ASTOME Phase II Randomized Controlled Trial",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "OTHER",
    "enrollmentCount": 200,
    "primaryOutcomeMeasure": "Evaluation of Network-oriented buomarkers in prognosis of BC",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Sporadic BC\n* Inherited BC\n* 18 years old\n* Males and Females\n\nExclusion Criteria:\n\n* Inflammatory diseases\n* Cardiovascular diseases",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}